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Abstract In milk, a stable fluid is formed in which sequestered nanoclusters of
calcium phosphate are substructures in casein micelles. As a result, calcium and
phosphate concentrations in milk can be far in excess of their solubility. Variations
of calcium, phosphate and casein concentrations in milks, both within and among
species, are mainly due to the formation of the nanocluster complexes. Caseins
evolved from tooth and bone proteins well before the evolution of lactation. It has
therefore been suggested that the role of caseins in milk is an adaptation of an
antecedent function in the control of some aspect of biomineralisation. There is
new evidence that nanocluster-type complexes are also present in blood serum
and, by implication, in many other closely related biofluids. Because such fluids
are stable but nevertheless supersaturated with respect to the bone and tooth
mineral hydroxyapatite, they allow soft and mineralised tissues to co-exist in the
same organism with relative ease. An appreciable concentration of nanocluster
complexes exists in fresh saliva. Such saliva may stabilise tooth mineral and help
to repair demineralised lesions. In the extracellular matrix of bone, nanocluster
complexes may be involved in directing the amorphous calcium phosphate to
intrafibrillar spaces in collagen where they can mature into oriented apatite
crystals. Thus, evidence is accumulating that calcium phosphate sequestration by
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phosphopeptides to form equilibrium complexes, first observed in milk, is more
generally important in the control of physiological calcification.
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1 Introduction
Research into the mechanisms of biomineralisation and the chemistry of the
mineral phases has been the subject of a number of excellent recent reviews
(George and Veis 2008; Wang and Nancollas 2009; Dorozhkin 2011). Hard
tissues include bone, cementum, dentine and enamel and contain a basic
calcium phosphate mineral called apatite, or hydroxyapatite, named by geolo-
gists from the Greek word apate meaning deceive because of the variable
crystal habit and composition of apatite rocks. Soft tissues and biofluids, by
contrast, contain little or no mineral in their normal, physiological state. Soft
tissues can become mineralised and hard tissues can become demineralised as a
result of degenerative, dysfunctional or diseased conditions, but normally,
tissues remain stably mineralised or unmineralised even though they are per-
meated by the same extracellular fluid. The problem of the easy co-existence of
soft and mineralised tissues in the same organism can be stated easily in terms
understandable to a chemist. For the hard tissue to stay mineralised, the
permeating biofluid must be supersaturated with respect to the hard tissue
mineral, and yet, for the soft tissues and biofluids to remain unmineralised,
the permeating biofluid must be stable.
A solution to the problem of the stability of biofluids must have been found
more than about 500 Ma ago when the first calcium phosphate mineralised
tissues appear in the fossil record. These include the cone-shaped denticles or
teeth of jawless fishes called conodonts. By about 50 Ma later, homologues of
the modern hard tissue types were established. For example, the bone-like head
plates of placoderms may have allowed sense organs, mounted on this stable
platform, to build up a three-dimensional picture of their environment. Con-
comitantly, a paralogous group of secreted, calcium (phosphate)-binding phos-
phoproteins evolved, called SCPPs (Kawasaki et al. 2004; Kawasaki and Weiss
2003). Members of this group of proteins are involved in every aspect of
biomineralisation. One of the earliest members of the group of SCPPs is
osteopontin which has a very wide occurrence in species, tissues and biofluids
(Mazzali et al. 2002).
Caseins are also members of the SCPP group, and it has been known for
many years that the colloidal calcium phosphate of casein micelles allows stable
milks to be formed, containing much higher calcium and phosphate concentra-
tions than are permitted by the solubility of inorganic calcium phosphates at
milk pH. Because of the ready availability of milk and the high concentrations
of the caseins responsible for its stability, we have been able to gain a deeper
understanding of the reasons for its stability than is available for any other
biofluid. These insights have led to an improved understanding of the sources
of stability in some other biofluids.
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In this review, we summarise some of the evidence of calcium phosphate
sequestration dairy chemistry in biofluids and soft and hard tissues. We believe
that a dialogue between the dairy chemistry and biomineralisation communities
would be to their mutual benefit.
2 Basic science of amorphous calcium phosphate sequestration
by phosphoproteins
2.1 Ostwald rule of stages
At physiological pH, calcium phosphate does not precipitate directly from
solution as the most thermodynamically stable phase, hydroxyapatite. Instead,
it passes through a number of unstable or metastable stages from the most
soluble to the least. Typically, an initial and highly unstable amorphous calcium
phosphate (ACP) phase, ACP-1, is succeeded by a more stable and less soluble
amorphous phase, ACP-2 (Christoffersen et al. 1990). It has been shown that
both amorphous phases had the same ratio of calcium to phosphate of 1.35
which is significantly lower than that of a basic tricalcium phosphate
(Ca/P=1.5) but above that of an acidic dicalcium phosphate (Ca/P=1.0). The
chemical formula Ca(PO4)0.52(HPO4)0.22 is consistent with Ca/P=1.35
(Christoffersen et al. 1990). In similar studies (Termine and Eanes 1972;
Meyer and Eanes 1978; Wuthier et al. 1985; Holt et al. 1989), the Ca/P ratio
of ACP has been reported to be as high as 1.5 and as low as 1.18, demon-
strating that a range of more-or-less acidic ACP phases are possible. Subse-
quently, poorly crystalline, impure and non-stoichiometric phases are formed,
the best characterised of which is octacalcium phosphate. The mineralised
tissues of bone, cementum and dentine all contain poorly crystalline calcium
phosphates of these sorts, but enamel comprises highly crystalline prisms of
almost pure hydroxyapatite.
2.2 Effect of phosphopeptides
Phosphoproteins and phosphopeptides can affect every aspect of the precipitation
process. For example the calcium-sensitive bovine caseins, even at very low concen-
trations, can extend the lag time before precipitation begins and slow down the rate of
maturation of the amorphous state. Phosphopeptides that contain three or more phos-
phorylated residues (usually seryl) in a short sequence are said to have a phosphate
centre (PC). If short, acidic, PC-containing peptides are present in stoichiometric excess
over the amount of amorphous calcium phosphate that forms from a supersaturated
solution, the solution remains apparently unchanged but contains calcium phosphate
nanoclusters with an outer shell of the phosphopeptides. Further investigations have
shown that the nanoclusters are equilibrium particles with a defined size and compo-
sition. In all other circumstances, a precipitate will develop, although the solution may
remain in a metastable state for some time. Certain highly phosphorylated phospho-
proteins such as the C-terminal regions of osteopontin or phosphophoryn appear to be
able to nucleate hydroxyapatite (Boskey et al. 2010).
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2.3 Ion activity product
The ion activity product has played an important part in the science of calcium
phosphate sequestration. For a generic chemical formula of an amorphous calcium
phosphate, containing both HPO4
2− and PO4
3− (Combes and Rey 2010)
Ca2þ þ yHPO2−4 þ
2 1−yð Þ
3
PO3−4 ↔ Ca HPO4ð Þy PO4ð Þ2 1−yð Þ
3
h i
solid
ð1Þ
the corresponding ion activity product is
KS ¼ Ca2þ
 
HPO2−4
 y
PO3−4
 2 1−yð Þ=3 ð2Þ
where the quantities in curly brackets are activities and the value of y determines how
acidic the amorphous phase is. For example, a basic tricalcium phosphate has y=0, the
ACP-1 and ACP-2 phases of Christoffersen et al. have y=0.22 and the acidic dicalcium
phosphates have y=1.0. We have used the ion activity product to show that sequestered
amorphous calcium phosphates can be acidic or basic salts depending on the seques-
tering phosphopeptide. For a solid phase in equilibrium with the continuous phase, the
corresponding ion activity product is invariant with respect to variation in the compo-
sition and pH of the fluid. Conversely, if an invariant ion activity is found in a fluid,
then the nature of the solid phase (for example, nanoclusters, amorphous or crystalline
calcium phosphates) with which it is in equilibrium can be inferred. This is true even if
the phase is present at a vanishingly small concentration. J.C. Elliot has written an
advanced treatise on calcium phosphates which includes values for the solubility
products of all the biologically relevant phases (Elliot 1994).
2.4 Application of a thermodynamic model to physiological fluids
The calculation of the ion equilibria in biological fluids on the assumption that all
components are in solution as simple ions and ion complexes is well established (for
references, see Holt et al. 2014). A tractable theory of the additional calculation of the
partition of salts between sequestered and free forms in a physiological fluid containing
phosphopeptides can be formulated on the assumption that there is a further equilibrium
reaction in which phosphopeptides bind strongly to amorphous calcium phosphate to
form a stoichiometric complex. Experimental evidence confirms that the sequestered
complexes have a constant composition and equilibrium size and the solution exhibits
an invariant ion activity product (Little and Holt 2004; Holt et al. 2009). A further
assumption is that all the phosphate centres have the same capacity to sequester
amorphous calcium phosphate and it may sometimes be necessary to know the ion
binding properties of free phosphate centres.
The simple ion equilibria calculations require the equilibrium constants for all the
ion complexes likely to be present (Holt et al. 1981; Mekmene et al. 2009, 2010; Lyster
1981; Rice et al. 2010; Holt 2004). The additional parameters needed for the partition
calculation are listed in Table 1. Each can be determined in independent experiments on
well-defined solutions in which there is a known PC-containing phosphopeptide.
Because of this and the fact that no fitting process with adjustable parameters is used
to describe the unknown fluid, we can describe the calculation as ab initio.
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Application of the model to simple nanocluster solutions and to milk has been
described (Little and Holt 2004; Holt 2004; Holt et al. 2009).
2.5 Stability diagram of biofluids
A special case of the calculation is for the condition that the concentration of phosphate
centres is the minimum needed to sequester the quantity of calcium phosphate formed
at equilibrium. The variation of the minimum concentration with pH has been used to
calculate the stability diagram for a variety of biofluids (Holt et al. 2014). An example
of the stability diagram for a bovine milk-like fluid is shown in Fig. 1.
The stability diagram defines areas of stability and instability. Below a certain pH,
called the critical pH, no phosphopeptides are needed to make the solution stable. As
pH increases, the minimum concentration of phosphate centres increases in a curvilin-
ear manner up to a plateau value somewhere above pH 8. Close to the boundary line,
on the higher pH side, is an ill-defined area of metastability where precipitation may be
delayed for some time.
If the solution is a biofluid and if the critical pH is below the physiological pH, then
it will be liable to precipitate calcium phosphate. Nevertheless, if it contains a sufficient
concentration of a sequestering phosphopeptide, it can be perfectly stable, even at the
physiological pH. At equilibrium it will contain nanoclusters of sequestered
Table 1 Parameters needed for the ab initio calculation of the partition of salts in a fluid
Parameter Description
C1, C2, Cn Concentrations of the n principal salts
RC1, RC1, RCn Molar ratio of each salt constituent to PC in the sequestered complex
[PC] Total concentration of phosphate centres
y Acidity parameter defined in Eq. (1)
KS Solubility constant or invariant ion activity product
v(C1, C2, Cn) Isotherm describing the simultaneous binding of the n principal salts to a free PC
Fig. 1 Stability diagram for a bovine milk-like fluid
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calcium phosphate. For the example calculation shown in Fig. 1, the physiological pH
is about 6.7 where a considerable concentration of phosphate centres is needed to
ensure stability.
3 Application to milk
In milk, the main source of phosphate centres is the calcium-sensitive caseins, but all
caseins contain adhesive sequences to promote mutual association. As a result, all milks
contain colloidal particles called casein micelles instead of individual nanoclusters.
Nevertheless, the casein micelle can be regarded as an assembly of nanoclusters. For
example, a bovine milk casein micelle with a radius of 100 nm is an assembly of about
800 nanoclusters and each nanocluster is formed from peptides containing about 50
phosphate centres (Holt et al. 2003). The average spacing between the nanoclusters is
about 18 nm which has been mistaken, in the past, for the diameter of protein
submicelles (McMahon and Oommen 2012).
Figure 2 shows that cow’s milk serum is highly supersaturated with respect to
hydroxyapatite and there is no invariant ion activity product for this phase. There is a
nearly invariant ion activity product for ACP-2, the more stable phase of amorphous
calcium phosphate, but the serum is supersaturated with respect to ACP-2. Milk serum
shows virtually the same invariant ion activity product as a solution of casein
nanoclusters (Little and Holt 2004).
When the quantitative predictions of the ab initio calculations of the partition of milk
salts are compared to experiment for individual cow milk samples with pH values in the
physiological range, the agreement between theory and experiment is very satisfactory
(Holt 2004). The extension of the theory to consider some of the non-physiological
conditions that are encountered during routine milk processing operations has also been
attempted. These include the effects of the adjustment of pH, addition or removal of
salts, addition of caseins, concentration and dilution on the partition of salts and the
Fig. 2 Saturation indices of bovine milk sera for hydroxyapatite (Holt 1982), ACP-2 (Christoffersen et al.
1990) and ACP sequestered by casein phosphopeptides (Little and Holt 2004). Calculations used the data of
individual milk samples in early, middle and late lactation (White and Davies 1958)
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dissociation of individual caseins from the casein micelle. Presently beyond the
capabilities of the model are the partition of micronutrients and radionuclides, the
effect of temperature and pressure and the consequences of all these manipulations
on the aggregation or gelation of milk proteins.
4 Application to other physiological fluids
Nearly all physiological fluids are supersaturated with respect to hydroxyapatite and
some other crystalline calcium phosphate phases. As a result, artificial biofluids that
closely resemble their natural counterparts in salt composition and pH are unstable and
will readily precipitate calcium phosphate. They, and natural biofluids, therefore require
some means to make them stable. Caseins are largely confined to expression in the
mammary gland, but other SCPPs are expressed in physiological fluids and hard and
soft tissues. Osteopontin (OPN), in particular, is almost universally expressed in
chordate tissues and biofluids (Mazzali et al. 2002). In the extracellular matrix of
mammalian bone, for example, it is the major non-collagenous phosphoprotein. It is
an unfolded flexible phosphoprotein, like other members of the group of SCPPs
(Fedarko et al. 2004; Fisher et al. 2001; Holt et al. 2009). It contains phosphate
centre-type sequences in its N-terminal half. We have previously shown that a naturally
occurring mixture of OPN phosphopeptides and a purified fraction of the N-terminal
phosphopeptides ending at or around residues 145 to 153 of the mature protein
(Christensen and Sorensen 2014) can sequester nanoclusters of amorphous calcium
phosphate (Holt et al. 2009, 2014).
4.1 Stability diagrams for stimulated saliva, blood serum and urine
The stability diagrams for salt solutions approximating the typical compositions of
three very different biofluids, urine, saliva and blood serum, have been calculated, on
the assumption that OPN phosphopeptides are responsible for sequestration, and
compared to experiment (Holt et al. 2014). For typical urine from non-stone formers,
the critical pH is well above the physiological pH so that normally the fluid is not
expected to be unstable with respect to calcium phosphate precipitation or to contain
calcium phosphate nanoclusters. However, when infected by microorganisms that
secrete urease, the pH may rise to above 10 and urolithiasis involving calcium
phosphate stones can result.
The stability diagram of typical human saliva is difficult to calculate because
the composition and pH are very variable. It is formed by mixing together
different secretions from three major and many other minor glands. This biofluid
is not very well buffered, so equilibration with air causes the pH to rise following
the loss of CO2. The results for stimulated saliva, however, are more reproducible,
and for this fluid, the physiological pH is above the critical pH. According to
experiment and calculation, stimulated saliva contains sequestered calcium phos-
phate (Grøn 1973; Holt et al. 2014) although the nature and amount of the
sequestering phosphoprotein or peptide are presently unknown.
The stability diagram has also been calculated for averaged blood serum
(Holt et al. 2014) from healthy individuals (Walser 1961, 1962). The
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physiological pH is close to or a little lower than the critical pH, and because
of the tight homeostasis of blood pH, we might not expect it to contain
sequestered amorphous calcium phosphate. The point is particularly important
for human health because vascular calcification is common in the final stages
of kidney failure and is associated with fatal heart attacks. We suggested (Holt
et al. 2014) that a background level of sequestering phosphopeptide was
desirable to cope with the inevitable fluctuations in composition and ensure
that precipitation of calcium phosphate arising from a fluctuation would be
fully reversed when homeostasis is restored. The major source of phosphate
centres is also uncertain with the principal candidates being OPN and fetuin A
(Heiss et al. 2010; Jahnen-Dechent et al. 2008, 2011; Wald et al. 2011a, b),
with contributions from other phosphoproteins (Price et al. 2003).
4.2 Ion activity products in stimulated saliva and blood serum
Calculated saturation indices for hydroxyapatite, ACP-2 and nanoclusters sequestered
by OPN peptides in fresh saliva and blood serum display a striking similarity to the
calculations for milk serum (Fig. 2). The invariant pKS values for fresh saliva, blood
serum and a pure nanocluster solution prepared from OPN peptides are 9.26±0.35,
9.27±0.13 and 9.12±0.05, respectively. These ion activity products are statistically
indistinguishable. It is hard to escape the conclusion that milk, blood and saliva all
contain similar forms of sequestered amorphous calcium phosphate, albeit at very
different concentrations.
5 Application to hard tissue mineralisation
The discussion so far has been concerned with the role of calcium phosphate
nanoclusters in forming stable biofluids, but these structures may be de-
stabilised or merely transient intermediates in the mineralisation of hard tissues.
A solution of ACP nanoclusters can retain its thermodynamic stability if three
conditions are satisfied (Holt et al. 2014). These are that (a) no further ACP
can form, (b) the sequestered ACP does not mature into a more crystalline
phase and (c) the solution is not in contact with a crystalline calcium phos-
phate. Condition c is violated in the mouth when saliva comes into contact with
the hydroxyapatite of tooth enamel. In contact with teeth, saliva brings about
remineralisation of demineralised tooth lesions. In other words, while the
nanocluster solution in isolation is thermodynamically stable, when brought
into contact with crystals of calcium phosphate, the crystals can grow at the
expense of the nanoclusters. In effect, the solution becomes unstable and acts
as a reservoir of calcium phosphate to support the growth of the more stable
phase. Condition b is the most intriguing one because of the apparently
conflicting literature on the roles of phosphoproteins in the inhibition and
nucleation of calcium phosphate precipitation. According to the theory of
calcium phosphate sequestration, the equilibrium size of the nanocluster in-
creases as the affinity of the peptide for the surface increases. A limited amount
of experimental data supports this proposition by showing that sequestration to
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form a stable complex requires a minimum of three phosphorylated residues in
a phosphate centre and that additional, flanking, Asp residues will increase the
nanocluster radius (Aoki et al. 1992; Clegg and Holt 2009). The logic is that
stronger peptide binding allows bigger clusters to be sequestered, but as the
cluster size increases, the probability rises of a more stable phase nucleating
and growing within the cluster. This is because there are more molecules that
could change in a larger cluster but also because the influence of the surface on
the interior of the cluster might only be effective over a limited depth below
the surface. Molecules beyond the influence of the surface can therefore behave
as if they are in an unstable bulk phase. The minimum size is zero when the
free energy of sequestration is zero. The largest known casein phosphate
centres, and hence, possibly, the phosphate centres with the highest binding
affinities, contain up to eight actual or potential phosphoseryl residues (Holt
et al. 2009), but some bone and dental peptides can contain much longer
phosphorylated sequences. In this context, it may be relevant that certain highly
phosphorylated phosphopeptides such as phosphophoryn appear to be able to
nucleate the growth of a solid phase and direct it to specific locations (Boskey
et al. 2010; Gericke et al. 2010). The ability of an acidic synthetic polymer,
poly-Asp, to promote intrafibrillar mineralisation of collagen has been described
(Olszta et al. 2003, 2007). The mechanism involves an amorphous precursor
phase which gathers near the gap zone of collagen fibres and then penetrates
the fibres to form a parallel array of oriented crystals of hydroxyapatite
(Nudelman et al. 2010). It has been suggested that the precursor phase is a
liquid-like pre-nucleation cluster for which there is some experimental evidence
in calcium carbonate nucleation studies (Gebauer and Coelfen 2011; Gebauer
et al. 2008). However, we consider it more likely that, given the abundance of
phosphoproteins, including osteopontin, in the extracellular matrix, the precur-
sor phase is a form of amorphous calcium phosphate stabilised by adsorbed
phosphopeptides. Indeed, it has been shown recently that the intrafibrillar
mineralisation of collagen can also be accomplished by the nanocluster-
forming mixture of OPN peptides (Rodriguez et al. 2014) as well as some
other phosphopeptides (Nudelman et al. 2012; Sfeir et al. 2014).
6 Conclusions and applications
The formation of thermodynamically stable nanoclusters of sequestered amorphous
calcium phosphate is well established in cow’s milk. The casein complexes are
probably responsible for most of the interspecific variation in calcium and phosphate
concentrations in all milks.
The theory of calcium phosphate sequestration is developing to the point where it
can make quantitative predictions of the concentrations of ions and nanocluster com-
plexes in quite complex media including physiological fluids other than milk and
proteins other than casein.
It is established that the protein OPN, which occurs in a wide distribution of
species, tissues and biofluids, can also sequester amorphous calcium phosphate
and form somewhat similar nanocluster complexes. The biofluids blood plasma
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and fresh saliva show an invariant ion activity product for nanoclusters seques-
tered by OPN phosphopeptides.
Amorphous calcium phosphate complexes with phosphoproteins may be formed
transiently in the mineralisation of hard tissues.
There are many possible applications of the science described in this paper. These
include, but are not limited to, biomimetic materials for the repair of bone fractures and
demineralised teeth, artificial biofluids with superior shelf life that can be used in the
irrigation of wounds during and after surgery, the irrigation of joints to help remove
erosive crystals from synovial spaces, artificial serum for rapid rehydration of
dehydrated patients and a superior kidney dialysis fluid that reproduces more closely
the composition of blood serum. Last but not least is a growth medium in tissue
engineering applications that can support the growth of mineralised tissues.
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